Cite
HARVARD Citation
Guo, B. et al. (2019). A Utility-Based Bayesian Phase I–II Design for Immunotherapy Trials with Progression-Free Survival End Point. Journal of the Royal Statistical Society. 68 (2), pp. 411-425. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Guo, B. et al. (2019). A Utility-Based Bayesian Phase I–II Design for Immunotherapy Trials with Progression-Free Survival End Point. Journal of the Royal Statistical Society. 68 (2), pp. 411-425. [Online].